Acquia today announced new capabilities for Acquia Cloud, extending the company’s strengths in security innovation and compliance for digital experience platforms. Additions include new tools to manage risk and updated compliance for a pair of key U.S.
EVERSOURCE ENERGY: Eversource Delivers Solar Power to the Grid, Bringing more Carbon-Free Energy to the Commonwealth
Following the construction of 19 new solar facilities across the commonwealth, Eversource is on track to deliver 62 megawatts of carbon-free, renewable energy to Bay State residents and businesses.
Flu season typically peaks in February: Abbott's technologies are ready to fight back.
BOSTON SCIENTIFIC CORPORATION: Boston Scientific Participates in FDA General Issues Panel on Transvaginal Surgical Mesh for Pelvic Organ Prolapse
On February 12, 2019, the U.S. Food and Drug Administration (FDA) convened an advisory panel of experts to discuss the safety and effectiveness of surgical mesh placed transvaginally to treat pelvic organ prolapse (POP).
BOSTON SCIENTIFIC CORPORATION: VICI VENOUS STENT® System Demonstrates Positive Clinical Outcomes in Patients with Deep Venous Blockages
Today, Boston Scientific (NYSE: BSX) announced positive 12-month data demonstrating that patients who were treated with the VICI VENOUS STENT® System for iliac and femoral vein obstructions exhibited a high rate of patent, or open, target lesions.
ADVANCED MEDICAL STRATEGIES: Treatment for Rare Blood Clotting Disorder Shows Efficacy in Phase 3 Study
New phase 3 data showed positive results for caplacizumab (Cablivi) in the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) in adults, according to a study published in the New England Journal of Medicine.
ADVANCED MEDICAL STRATEGIES: Massachusetts Initiative Looks at Payment Plans for Novartis’ SMA Gene Therapy
Many of the new biologic drugs and gene therapies coming on the market have shockingly high prices.
The FDA is creating an office of drug development science to cut the cost of bringing new medicines to patients, BioCentury reports.
The Massachusetts Coalition for Sustainable Energy (MCSE) continues to add members.
Researchers in Australia have developed a 10-minute test that can detect the presence of cancer cells anywhere in the human body, according to a newly published study.
Aqueduct Technologies Inc. announced that it has met all requirements to achieve the Cisco® Master Data Center and Hybrid Cloud Specialization.
In an effort to address the region’s worsening housing crisis, Newton Mayor Ruthanne Fuller has joined a coalition of 15 local mayors who are to committed to creating 185,000 new units of housing across the region by the year 2030.
Many insurers current portals were developed more than a decade ago, and, insurer CIOs are looking to provide enhanced user experience as ease-of-doing-business remains a key competitive issue.
Boston Scientific Corporation (NYSE: BSX) today announced the District Court of Dusseldorf, Germany has determined that Edwards Lifesciences Corporation's Sapien 3 Ultra™ device infringed a patent – established by Symetis SA, a subsidiary of Boston Scientific – specific to the fabric used on the valve seal, specifically the German part of European Patent (EP) 2 949 292 B1.
Aqueduct President & CEO, Manak Ahluwalia shares his insight with CRN into the state of the economy and the impact it is having on information technology spending and the solution provider landscape.